Journal of Experimental & Clinical Cancer Research (Jan 2023)

Correction: Resveratrol reverses Doxorubicin resistance by inhibiting epithelial-mesenchymal transition (EMT) through modulating PTEN/ Akt signaling pathway in gastric cancer

  • Jiahui Xu,
  • Deying Liu,
  • Huilin Niu,
  • Guifang Zhu,
  • Yangwei Xu,
  • Danli Ye,
  • Jian Li,
  • Qingling Zhang

DOI
https://doi.org/10.1186/s13046-023-02593-5
Journal volume & issue
Vol. 42, no. 1
pp. 1 – 2

Abstract

Read online

No abstracts available.